Psychiatry News

The U.S. Food and Drug Administration published a final rule raising the age of certain restrictions on the sale of tobacco products, according to an agency press release.

Most Americans feel they would not be ready to help in the event of a drug overdose, according to the results of a recent survey.

Clinicians will gather for AIMed24 to meet with industry leaders and innovators and attend keynotes and workshops to discuss the future of AI implementation in medicine, according to information from the meeting organizers.

Placebos administered without deception, or nondeceptive placebos, may offer an alternative and effective way to help people manage prolonged stress, according to a study published in Applied Psychology: Health and Well-Being.

Attempts to curtail prior authorizations for patients insured by Medicare Advantage plans have failed in back-to-back legislative sessions in 2019 and 2021, but a new bill has some experts hopeful that the third time is a charm.

Female physicians face an increased risk for suicide despite suicide rates among physicians decreasing over time, a systematic review and meta-analysis published in BMJ showed.

Aug. 31 is International Overdose Awareness Day. It is a time to remember those lost to substance use disorders and addiction, particularly as the United States and countries around the globe grapple with the opioid crisis.

Children with medical complexity were twice as likely to be diagnosed with a neurodevelopmental or mental health condition, according to findings published in Pediatrics.

NEW YORK — In this Healio Video Perspective, Hyun Jung Kim, MD, discusses the format of her presentation on the relationship between cannabis use and risk for psychosis at the American Psychiatric Association Annual Meeting.

In the third episode of the NSAIDs saga, we focus on COX-2 inhibition! Did the hopes and dreams of selective COX-2 inhibition pan out? What can the rise and fall of VIOXX teach us about physiology?